Stay updated on Intrathecal RO7234292 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Intrathecal RO7234292 in Huntington's Disease Clinical Trial page.

Latest updates to the Intrathecal RO7234292 in Huntington's Disease Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a newer document version associated with the page. This is a metadata change reflecting an update to the page’s documentation rather than a change to study data or details.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study page now states that it is no longer looking for participants, indicating enrollment for this Huntington's disease trial has closed. In addition, new navigation/help items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, a header label was refined from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag updated to v3.6.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA revision tag with value v3.5.5 was added. The previous tag v3.5.4 was removed.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page's revision tag has been updated to v3.5.4, replacing the previous v3.5.3, indicating a recent deployment of updates to the page.SummaryDifference0.0%

- Check57 days agoChange DetectedA new bibliographic reference has been added to the Publications section. The reference documents a 2026 NPJ Digital Medicine study on digital passive monitoring of chorea in Huntington's disease.SummaryDifference0.0%

- Check65 days agoChange DetectedThis page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a technical/version change to the website rather than any change to the study record.SummaryDifference0.0%

Stay in the know with updates to Intrathecal RO7234292 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intrathecal RO7234292 in Huntington's Disease Clinical Trial page.